2026-05-20T23:32:10Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/149312024-09-27T17:38:08Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19608

00925njm 22002777a 4500 dc Beeton, Michael L author Zhang, Xu-Sheng author Uldum, Søren A author Bébéar, Cécile author Dumke, Roger author Gullsby, Karolina author Ieven, Margareta author Loens, Katherine author Nir-Paz, Ran author Pereyre, Sabine author Spiller, O Brad author Chalker, Victoria J author ESCMID Study Group for Mycoplasma author Chlamydia Infections (ESGMAC) Mycoplasma pneumoniae subgroup author Cano-Portero, Rosa author 2020-01 Background: Mycoplasma pneumoniae is a leading cause of community-acquired pneumonia, with large epidemics previously described to occur every 4 to 7 years. Aim: To better understand the diagnostic methods used to detect M. pneumoniae; to better understand M. pneumoniae testing and surveillance in use; to identify epidemics; to determine detection number per age group, age demographics for positive detections, concurrence of epidemics and annual peaks across geographical areas; and to determine the effect of geographical location on the timing of epidemics. Methods: A questionnaire was sent in May 2016 to Mycoplasma experts with national or regional responsibility within the ESCMID Study Group for Mycoplasma and Chlamydia Infections in 17 countries across Europe and Israel, retrospectively requesting details on M. pneumoniae-positive samples from January 2011 to April 2016. The Moving Epidemic Method was used to determine epidemic periods and effect of country latitude across the countries for the five periods under investigation. Results: Representatives from 12 countries provided data on M. pneumoniae infections, accounting for 95,666 positive samples. Two laboratories initiated routine macrolide resistance testing since 2013. Between 2011 and 2016, three epidemics were identified: 2011/12, 2014/15 and 2015/16. The distribution of patient ages for M. pneumoniae-positive samples showed three patterns. During epidemic years, an association between country latitude and calendar week when epidemic periods began was noted. Conclusions: An association between epidemics and latitude was observed. Differences were noted in the age distribution of positive cases and detection methods used and practice. A lack of macrolide resistance monitoring was noted. Euro Surveill. 2020 Jan;25(2):1900112. 10.2807/1560-7917.ES.2020.25.2.1900112 1560-7917 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 31964459 http://hdl.handle.net/20.500.12105/14931 Mycoplasma pneumoniae Diagnostics Epidemiology Surveillance Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016